Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Dermatology

  Free Subscription


13.05.2019

4 Am J Dermatopathol
4 BMC Cancer
4 Br J Dermatol
1 Cancer
5 Clin Exp Dermatol
1 Cutis
5 Int J Cancer
3 Int J Dermatol
1 Intern Med
2 J Cutan Pathol
12 J Dermatol
4 J Invest Dermatol
3 Lancet
1 Lancet Infect Dis
2 Lancet Oncol
6 N Engl J Med
1 PLoS Biol
9 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. MITEVA M, Sabiq S
    A New Histologic Pattern in 6 Biopsies From Early Frontal Fibrosing Alopecia.
    Am J Dermatopathol. 2019;41:118-121.
    PubMed     Text format     Abstract available

  2. LOPEZ-ROBLES J, Perez-Plaza A, Requena L, Santonja C, et al
    Osteoma Cutis Arising in Common Blue Nevus (Blue Osteonevus): A Clinicopathologic, Immunohistochemical, and Dermoscopic Study.
    Am J Dermatopathol. 2019;41:e19-e21.
    PubMed     Text format     Abstract available

  3. MCKISSACK SS, Wohltmann W, Dalton SR, Miletta NR, et al
    Squamoid Eccrine Ductal Carcinoma: An Aggressive Mimicker of Squamous Cell Carcinoma.
    Am J Dermatopathol. 2019;41:140-143.
    PubMed     Text format     Abstract available

  4. MAHMOUD EA, Elgarhy LH, Hasby EA, Mohammad L, et al
    Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients.
    Am J Dermatopathol. 2019;41:122-127.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. DARLIX A, Hirtz C, Thezenas S, Maceski A, et al
    The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    BMC Cancer. 2019;19:110.
    PubMed     Text format     Abstract available

  6. SUAREZ-KELLY LP, Pasley WH, Clayton EJ, Povoski SP, et al
    Effect of topical microporous polysaccharide hemospheres on the duration and amount of fluid drainage following mastectomy: a prospective randomized clinical trial.
    BMC Cancer. 2019;19:99.
    PubMed     Text format     Abstract available

  7. MUMIN NH, Drobnitzky N, Patel A, Lourenco LM, et al
    Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
    BMC Cancer. 2019;19:102.
    PubMed     Text format     Abstract available

  8. SCHAFFAR R, Belot A, Rachet B, Woods L, et al
    On the use of flexible excess hazard regression models for describing long-term breast cancer survival: a case-study using population-based cancer registry data.
    BMC Cancer. 2019;19:107.
    PubMed     Text format     Abstract available


    Br J Dermatol

  9. CSOMA ZR, Kemeny L
    Image Gallery: Acquired zinc deficiency of prematurity.
    Br J Dermatol. 2018;178:e144.
    PubMed     Text format    

  10. ELLIS R, Tang D, Nasr B, Greenwood A, et al
    Epidermal AMBRA1 and Loricrin; a paradigm shift in the prognostication and stratification of AJCC stage I melanomas.
    Br J Dermatol. 2019 May 6. doi: 10.1111/bjd.18086.
    PubMed     Text format     Abstract available

  11. CLAYTON RW, Gobel K, Niessen CM, Paus R, et al
    Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis.
    Br J Dermatol. 2019 May 6. doi: 10.1111/bjd.17981.
    PubMed     Text format     Abstract available

  12. MATTERNE U, Baumeister SE, Apfelbacher C
    Suicidality and risk of suicidality in psoriasis: A critical appraisal of two systematic reviews and meta-analyses.
    Br J Dermatol. 2019 May 10. doi: 10.1111/bjd.18108.
    PubMed     Text format     Abstract available


    Cancer

  13. NAJJAR YG, Puligandla M, Lee SJ, Kirkwood JM, et al
    An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanoma.
    Cancer. 2019 May 8. doi: 10.1002/cncr.32162.
    PubMed     Text format     Abstract available


    Clin Exp Dermatol

  14. SACCHELLI L, Patrizi A, Loi C, Bardazzi F, et al
    Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis.
    Clin Exp Dermatol. 2019 May 4. doi: 10.1111/ced.14000.
    PubMed     Text format     Abstract available

  15. MCSWEENEY SM, Woolf RT, Calonje E, Lewis F, et al
    Just vulval lichen simplex?
    Clin Exp Dermatol. 2019 May 3. doi: 10.1111/ced.13982.
    PubMed     Text format    

  16. FERRIERES L, Konstantinou MP, Bulai Livideanu C, Hegazy S, et al
    Long-term maintenance of secukinumab in psoriasis: association with patient profile and initial psoriasis clearance.
    Clin Exp Dermatol. 2019 May 4. doi: 10.1111/ced.13999.
    PubMed     Text format     Abstract available

  17. FENG X, Yang M, Yang Z, Qian Q, et al
    Abnormal expression of the co-stimulatory molecule B7-H3 in Lichen simplex chronicus is associated with Langerhans cells expansion.
    Clin Exp Dermatol. 2019 May 5. doi: 10.1111/ced.14001.
    PubMed     Text format     Abstract available

  18. GOHAR A
    Lungs, methotrexate and psoriasis: reply from author.
    Clin Exp Dermatol. 2019 May 6. doi: 10.1111/ced.14002.
    PubMed     Text format     Abstract available


    Cutis

  19. KIRCIK LH, Lin T, Pillai R
    Scientific Abstracts. Skin Disease Education Foundation's 43rd Annual Hawaii Dermatology Seminar.
    Cutis. 2019;103.
    PubMed     Text format     Abstract available


    Int J Cancer

  20. GAUDET MM, Deubler EL, Kelly RS, Diver WR, et al
    Blood Levels of Cadmium and Lead in Relation to Breast Cancer Risk in Three Prospective Cohorts.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31805.
    PubMed     Text format     Abstract available

  21. LI J, Wen WX, Eklund M, Kvist A, et al
    Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
    Int J Cancer. 2018 Sep 2. doi: 10.1002/ijc.31841.
    PubMed     Text format     Abstract available

  22. BULANOVA DR, Helenius M, Sokolenko AP, Kuznetsov SG, et al
    Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
    Int J Cancer. 2018 Nov 25. doi: 10.1002/ijc.32013.
    PubMed     Text format    

  23. KLASCHIK K, Hauke J, Neidhardt G, Trankle C, et al
    The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
    Int J Cancer. 2018 Nov 26. doi: 10.1002/ijc.32016.
    PubMed     Text format    

  24. CORTESI L, Canossi B, Battista R, Pecchi A, et al
    Breast ultrasonography in the screening protocol for women at hereditary- familial risk of breast cancer: Has the time come to rethink the role of BU according to different risk categories?
    Int J Cancer. 2018 Aug 11. doi: 10.1002/ijc.31794.
    PubMed     Text format     Abstract available


    Int J Dermatol

  25. SIEGEL DR, Schneider SL, Chaffins M, Rambhatla PV, et al
    A retrospective review of 93 cases of cellular dermatofibromas.
    Int J Dermatol. 2019 May 10. doi: 10.1111/ijd.14472.
    PubMed     Text format     Abstract available

  26. TIDWELL WJ, Sutton A, Gilbertson R, Humberson C, et al
    Basal cell carcinoma of the groin and buttocks: a clinical and histological analysis of a rare presentation of a common tumor.
    Int J Dermatol. 2019 May 9. doi: 10.1111/ijd.14477.
    PubMed     Text format     Abstract available

  27. EISENDLE K, Thuile T, Puviani M, Pichler M, et al
    Successful treatment of an extensive abrasion ulcer in chronic atrophic skin with a porcine xenograft after failure of multiple treatment modalities.
    Int J Dermatol. 2019 May 7. doi: 10.1111/ijd.14478.
    PubMed     Text format    


    Intern Med

  28. SAKAMOTO N, Ishimoto H, Nakashima S, Yura H, et al
    Clinical Features of anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis: A Case Series.
    Intern Med. 2018 Nov 19. doi: 10.2169/internalmedicine.1516.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  29. HEDAYAT AA, Lefferts JA, Atkinson AE, Busam KJ, et al
    BAP1-Deficient Tumor/Nevus with Germline Aberration: A Potential Pitfall in assessing Melanocytic Neoplasms with Single Nucleotide Polymorphism array.
    J Cutan Pathol. 2019 May 6. doi: 10.1111/cup.13488.
    PubMed     Text format     Abstract available

  30. ROY SF, Ghazawi FM, Tran D, Bouffard D, et al
    Cutaneous Plasmacytosis and Multinucleate Cell Angiohistiocytoma-Like Reaction in a Patient with Hepatitis B: A Fortuitous Triad?
    J Cutan Pathol. 2019 May 9. doi: 10.1111/cup.13491.
    PubMed     Text format     Abstract available


    J Dermatol

  31. FUSUMAE T, Tanese K, Takeuchi A, Takasugi A, et al
    High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT.
    J Dermatol. 2019;46:57-60.
    PubMed     Text format     Abstract available

  32. YONG SB, Su KW, Chen HH, Huang JY, et al
    Impact of chronic urticaria on systemic lupus erythematosus: A nationwide population-based study in Taiwan.
    J Dermatol. 2019;46:26-32.
    PubMed     Text format     Abstract available

  33. HO YH, Hu HY, Chang YT, Li CP, et al
    Psoriasis is associated with increased risk of bullous pemphigoid: A nationwide population-based cohort study in Taiwan.
    J Dermatol. 2019 May 7. doi: 10.1111/1346-8138.14902.
    PubMed     Text format     Abstract available

  34. SAWABE Y, Hayashi K, Kamata M, Nagata M, et al
    Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14.
    J Dermatol. 2019 May 7. doi: 10.1111/1346-8138.14909.
    PubMed     Text format    

  35. LEYS L, Wang Y, Paulsboe S, Edelmayer R, et al
    Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice.
    J Dermatol. 2019 May 7. doi: 10.1111/1346-8138.14899.
    PubMed     Text format     Abstract available

  36. SATO Y, Fujimura T, Mizuashi M, Aiba S, et al
    Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
    J Dermatol. 2019 May 7. doi: 10.1111/1346-8138.14906.
    PubMed     Text format    

  37. NAM JH, Yang J, Park J, Seo JH, et al
    Association between rosacea severity and relative muscle mass: A cross-sectional study.
    J Dermatol. 2019;46:11-17.
    PubMed     Text format     Abstract available

  38. HIRAI Y, Miyake T, Hamada T, Yamasaki O, et al
    Autophagy in malnutrition-associated dermatoses.
    J Dermatol. 2019;46:43-47.
    PubMed     Text format     Abstract available

  39. KAMIJO H, Miyagaki T, Norimatsu Y, Shishido-Takahashi N, et al
    Sezary syndrome without erythroderma: A case report and review of published work.
    J Dermatol. 2019;46:61-64.
    PubMed     Text format     Abstract available

  40. MOTEGI SI, Sekiguchi A, Yonemoto Y, Mieda T, et al
    Demographic and clinical characteristics of spinal calcinosis in systemic sclerosis: Possible association with peripheral angiopathy.
    J Dermatol. 2019;46:33-36.
    PubMed     Text format     Abstract available

  41. MATSUDA T, Yamazaki F, Ueda-Hayakawa I, Kambe N, et al
    Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
    J Dermatol. 2019;46:70-72.
    PubMed     Text format     Abstract available

  42. KOHSAKA H, Mimori T, Kanda T, Shimizu J, et al
    Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    J Dermatol. 2019;46:e1-e18.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  43. MATSUMURA W, Fujita Y, Shinkuma S, Suzuki S, et al
    Cultured epidermal autografts from clinically revertant skin as a potential wound treatment for recessive dystrophic epidermolysis bullosa.
    J Invest Dermatol. 2019 May 2. pii: S0022-202X(19)31497.
    PubMed     Text format     Abstract available

  44. DEL DUCA E, Pavel AB, Dubin C, Song T, et al
    Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals.
    J Invest Dermatol. 2019 May 3. pii: S0022-202X(19)31498.
    PubMed     Text format    

  45. ROUILLE T, Aractingi S, Kadlub N, Fraitag S, et al
    Local inhibition of MEK/AKT prevents cellular growth in human congenital melanocytic nevi.
    J Invest Dermatol. 2019 May 3. pii: S0022-202X(19)31499.
    PubMed     Text format     Abstract available

  46. SOENEN R, Meulewaeter E, Grine L, Van den Berghe N, et al
    Defining a minimal effective serum trough concentration of secukinumab in psoriasis: a step towards personalized therapy.
    J Invest Dermatol. 2019 May 5. pii: S0022-202X(19)31504.
    PubMed     Text format    


    Lancet

  47. HAMADA H, Suzuki H, Onouchi Y, Ebata R, et al
    Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised
    Lancet. 2019 Mar 7. pii: S0140-6736(18)32003.
    PubMed     Text format     Abstract available

  48. HURVITZ SA
    Dose intensification of chemotherapy for early breast cancer in the age of de-escalation.
    Lancet. 2019 Feb 7. pii: S0140-6736(19)30197.
    PubMed     Text format    


  49. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
    Lancet. 2019 Feb 7. pii: S0140-6736(18)33137.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  50. ARKELL P, Macallan D, Rees A, Finer N, et al
    Severe intraocular herpes simplex virus type-1 infection after 46 years of latency.
    Lancet Infect Dis. 2018;18:1046.
    PubMed     Text format    


    Lancet Oncol

  51. PE M, Dorme L, Coens C, Basch E, et al
    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
    Lancet Oncol. 2018;19:e459-e469.
    PubMed     Text format     Abstract available

  52. GOURD E
    New triple-negative breast cancer risk genes identified.
    Lancet Oncol. 2018 Aug 16. pii: S1470-2045(18)30614.
    PubMed     Text format    


    N Engl J Med

  53. SAUN TJ, Truong J, Dev SP, Wanzel K, et al
    How to Perform an Elliptical Excision of the Skin.
    N Engl J Med. 2019;380:e34.
    PubMed     Text format    

  54. EVERETT L, Copperman T
    Metastatic Uveal Melanoma.
    N Engl J Med. 2019;380:1853.
    PubMed     Text format    

  55. PALLOK K, De Maio F, Ansell DA
    Structural Racism - A 60-Year-Old Black Woman with Breast Cancer.
    N Engl J Med. 2019;380:1489-1493.
    PubMed     Text format    

  56. WANG CY, Wong WW, Tsai HC, Chen YH, et al
    Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
    N Engl J Med. 2019;380:1535-1545.
    PubMed     Text format     Abstract available

  57. FLOREZ-POLLACK S, Mauskar MM
    Disseminated Gonococcal Infection.
    N Engl J Med. 2019;380:1565.
    PubMed     Text format    

  58. WALKER SP
    The ROC Curve Redefined - Optimizing Sensitivity (and Specificity) to the Lived Reality of Cancer.
    N Engl J Med. 2019;380:1594-1595.
    PubMed     Text format    


    PLoS Biol

  59. CHEN W, Qin Y, Wang D, Zhou L, et al
    CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer.
    PLoS Biol. 2018;16:e2005869.
    PubMed     Text format     Abstract available


    PLoS One

  60. SUN L, Legood R, Dos-Santos-Silva I, Gaiha SM, et al
    Global treatment costs of breast cancer by stage: A systematic review.
    PLoS One. 2018;13:e0207993.
    PubMed     Text format     Abstract available

  61. VICENTE CR, Falqueto A
    Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis.
    PLoS One. 2018;13:e0208208.
    PubMed     Text format     Abstract available

  62. BOU-DARGHAM MJ, Liu Y, Sang QA, Zhang J, et al
    Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
    PLoS One. 2018;13:e0207799.
    PubMed     Text format     Abstract available

  63. KOUTRAS A, Lazaridis G, Koliou GA, Kouvatseas G, et al
    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
    PLoS One. 2018;13:e0207707.
    PubMed     Text format     Abstract available

  64. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    PubMed     Text format     Abstract available

  65. BANG JI, Yoon HJ, Kim BS
    Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.
    PLoS One. 2018;13:e0208861.
    PubMed     Text format     Abstract available

  66. CINGIR KOKER S, Jahja E, Shehwana H, Keskus AG, et al
    Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.
    PLoS One. 2018;13:e0208982.
    PubMed     Text format     Abstract available

  67. MADDEN JM, Duffy MJ, Zgaga L, Bennett K, et al
    Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study.
    PLoS One. 2018;13:e0209033.
    PubMed     Text format     Abstract available

  68. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  69. JIA D, Lu M, Jung KH, Park JH, et al
    Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Proc Natl Acad Sci U S A. 2019;116:3909-3918.
    PubMed     Text format     Abstract available

  70. BLASCO-BENITO S, Moreno E, Seijo-Vila M, Tundidor I, et al
    Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815034116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: